Zyx Citron 3 mg lozenges

Zyx is a well-known medicated lozenge brand primarily used for the symptomatic treatment of pain and irritation in the mouth and throat. The active ingredient, benzydamine hydrochloride, provides local analgesic and anti-inflammatory effects. The Zyx brand has deep roots in the European pharmaceutical market, particularly in the Nordic regions, where it has been a staple for throat care.

The brand was originally part of the portfolio of Meda AB, a Swedish specialty pharmaceutical company. However, through a series of major global mergers and acquisitions, the ownership has transitioned. Meda AB was acquired by Mylan in 2016. Subsequently, Mylan merged with Pfizer's Upjohn division in 2020 to form Viatris Inc. Today, Viatris, a global healthcare company headquartered in the United States, is the ultimate owner of the brand. Manufacturing for Zyx products, including these lozenges, is typically concentrated in Italy at specialized pharmaceutical facilities.